Foclivia

Foclivia is an influenza vaccine designed to protect against the H5N1 strain. It contains inactivated surface antigens to stimulate immunity. Ideal for seasonal flu prevention, this vaccine is administered intramuscularly.

Foclivia is used to prevent influenza caused by the H5N1 strain. It is particularly relevant for individuals at risk of exposure to this specific virus. The vaccine works by triggering the body's immune response to develop antibodies against the influenza virus, providing protection against infection.

Common effects of Foclivia may include mild soreness, redness, or swelling at the injection site. Some individuals might experience temporary fatigue, headache, or low-grade fever following vaccination. These effects are generally mild and short-lived.

Foclivia should be administered by healthcare professionals. Individuals with a history of severe allergic reactions to previous influenza vaccines or any of its components should avoid this vaccine. Always inform your healthcare provider about any existing medical conditions or allergies before receiving the vaccine.

Foclivia may interact with certain medications or other vaccines. It is important to discuss any current medications or recent vaccinations with a healthcare provider before receiving Foclivia. Alcohol and other immune-suppressing substances may affect the vaccine's effectiveness.